相关实验视频
Updated: Jul 16, 2025

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 15, 2010
一个真实世界的药监测研究FDA不良事件报告系统事件的西尔代纳菲尔
Yan Wang1, Bin Zhao2,3, Haiyan Yang4
1Medical Reproductive Center, People's Hospital of Jiuquan City, Jiuquan, Gansu, China.
这项研究分析了FDA对西尔德纳菲尔的数据,揭示了包括视力问题,听力损失和罕见癌症在内的严重不良事件. 这些发现强调了对这种勃起功能障碍药物的持续安全监测的必要性.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 医疗信息学 医疗信息学
背景情况:
- 西尔德纳菲尔是一种常见的固酶5型 (PDE5) 抑制剂,用于治疗勃起功能障碍 (ED).
- 对西尔代纳菲尔的安全性和不良事件 (AE) 的全面评估至关重要.
研究的目的:
- 为了评估与西尔代纳菲尔使用相关的不良事件 (AE).
- 使用药监数据识别潜在的安全信号.
主要方法:
- 对FDA不良事件报告系统 (FAERS) 数据库的回顾性分析.
- 使用一个案例/非案例设计和统计算法 (ROR,PRR,BCPNN,MGPS) 来检测安全信号.
主要成果:
- 分析了339,230份报告中的33,692份西尔代纳菲尔报告.
- 在60岁以上的男性中,AE最常见;美国的报道最高.
- 确定了严重的结局 (死亡,残疾) 和重要的器官系统类别,包括生殖,瘤,血管和血液/淋巴系统疾病.
- 值得注意的首选术语包括视力模糊,脸红,突然听力损失,疼痛勃起和priapism.
- 发现了意想不到的副作用:恶性黑色素瘤,肺高血压,获得的血友病和大动脉剖析.
结论:
- 这些发现强调了监测西尔德纳菲尔的潜在风险的重要性.
- 需要进一步的研究来验证确定的关联,并解决未被认可的安全问题.
更多相关视频
14:55Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
09:39Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Drug Regulation
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview